Survival assay of transiently transfected dopaminergic neurons

Journal of Neuroscience Methods

Volumn 169, Issue 1, 2008, Pages 8-15

  Yu, Li ying ^a   Arumäe, Urmas ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Caspase 6; Death pathways; Dopaminergic neurons; GDNF; Survival assay; Transfection

Indexed keywords

CALCIUM PHOSPHATE; CASPASE 6; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GREEN FLUORESCENT PROTEIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASSAY; CELL MIGRATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BIOLOGICAL ASSAY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALCIUM PHOSPHATES; CASPASE 6; CELL CULTURE TECHNIQUES; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; GREEN FLUORESCENT PROTEINS; MESENCEPHALON; MICE; MICROSCOPY, CONFOCAL; NEURONS; SIGNAL TRANSDUCTION; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

EID: 39749108067     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2007.11.018     Document Type: Article

References (35)

1. Airaksinen M.S., and Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3 (2002) 383-394
2. Barde Y.A. Trophic factors and neuronal survival. Neuron 2 (1989) 1525-1534
3. Bergman H., and Deuschl G. Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord 17 Suppl 3 (2002) S28-S40
4. Bespalov M.M., and Saarma M. GDNF family receptor complexes are emerging drug targets. Trends Pharmacol 28 (2007) 68-74
5. Bredesen D.E., Rao R.V., and Mehlen P. Cell death in the nervous system. Nature 443 (2006) 796-802
6. Burke R.E., Antonelli M., and Sulzer D. Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J Neurochem 71 (1998) 517-525
7. Chang L.K., Putcha G.V., Deshmukh M., and Johnson Jr. E.M. Mitochondrial involvement in the point of no return in neuronal apoptosis. Biochimie 84 (2002) 223-231
8. Clarke P.G. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol (Berl) 181 (1990) 195-213
9. Danial N.N., and Korsmeyer S.J. Cell death. Critical control points. Cell 116 (2004) 205-219
10. Fadeel B., and Orrenius S. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 258 (2005) 479-517
11. Gibson R.M. Does apoptosis have a role in neurodegeneration?. BMJ 322 (2001) 1539-1540
12. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9 (2003) 589-595
13. Jäättelä M. Programmed cell death: many ways for cells to die decently. Ann Med 34 (2002) 480-488
14. Jackson-Lewis V., Vila M., Djaldetti R., Guegan C., Liberatore G., Liu J., et al. Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J Comp Neurol 424 (2000) 476-488
15. Jenner P., and Olanow C.W. The pathogenesis of cell death in Parkinson's disease. Neurology 66 (2006) S24-S36
16. Johnson Jr. E.M., and Deckwerth T.L. Molecular mechanisms of developmental neuronal death. Annu Rev Neurosci 16 (1993) 31-46
17. Krieglstein K. Cell death in the nervous system. Adv Exp Med Biol 557 (2006) 1-10
18. Krieglstein K., Maysinger D., and Unsicker K. The survival response of mesencephalic dopaminergic neurons to the neurotrophins BDNF and NT-4 requires priming with serum: comparison with members of the TGF-beta superfamily and characterization of the serum-free culture system. J Neural Transm Suppl 47 (1996) 247-258
19. Lang A.E., Gill S., Patel N.K., Lozano A., Nutt J.G., Penn R., et al. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol 59 (2006) 459-466
20. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., and Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260 (1993) 1130-1132
21. Lindholm P., Voutilainen M.H., Lauren J., Peränen J., Leppänen V.M., Andressoo J.O., et al. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature 448 (2007) 73-77
22. Lockshin R.A., and Zakeri Z. Apoptosis, autophagy, and more. Int J Biochem Cell Biol 36 (2004) 2405-2419
23. Mehlen P., and Bredesen D.E. The dependence receptor hypothesis. Apoptosis 9 (2004) 37-49
24. Mehlen P., Rabizadeh S., Snipas S.J., Assa-Munt N., Salvesen G.S., and Bredesen D.E. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395 (1998) 801-804
25. Oo T.F., Kholodilov N., and Burke R.E. Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo. J Neurosci 23 (2003) 5141-5148
26. Oo T.F., Ries V., Cho J., Kholodilov N., and Burke R.E. Anatomical basis of glial cell line-derived neurotrophic factor expression in the striatum and related basal ganglia during postnatal development of the rat. J Comp Neurol 484 (2005) 57-67
27. Oppenheim R.W. Cell death during development of the nervous system. Annu Rev Neurosci 14 (1991) 453-501
28. Riedl S.J., and Salvesen G.S. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 8 (2007) 405-413
29. Sawamoto K., Nakao N., Kobayashi K., Matsushita N., Takahashi H., Kakishita K., et al. Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons. Proc Natl Acad Sci USA 98 (2001) 6423-6428
30. Slevin J.T., Gerhardt G.A., Smith C.D., Gash D.M., Kryscio R., and Young B. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J Neurosurg 102 (2005) 216-222
31. Takeshima T., Shimoda K., Johnston J.M., and Commissiong J.W. Standardized methods to bioassay neurotrophic factors for dopaminergic neurons. J Neurosci Methods 67 (1996) 27-41
32. Thorburn A. Death receptor-induced cell killing. Cell Signal 16 (2004) 139-144
33. Vila M., and Przedborski S. Targeting programmed cell death in neurodegenerative diseases. Nat Rev Neurosci 4 (2003) 365-375
34. Yang J., Lindahl M., Lindholm P., Virtanen H., Coffey E., Runeberg-Roos P., et al. PSPN/GFRalpha4 has a significantly weaker capacity than GDNF/GFRalpha1 to recruit RET to rafts, but promotes neuronal survival and neurite outgrowth. FEBS Lett 569 (2004) 267-271
35. Yu L.Y., Jokitalo E., Sun Y.F., Mehlen P., Lindholm D., Saarma M., et al. GDNF-deprived sympathetic neurons die via a novel nonmitochondrial pathway. J Cell Biol 163 (2003) 987-997